Dj. Rawlings et al., DIFFERENTIATION OF HUMAN CD34(-)CORD BLOOD STEM-CELLS INTO B-CELL PROGENITORS IN-VITRO()CD38(), Experimental hematology, 25(1), 1997, pp. 66-72
Umbilical cord blood CD34(+)CD38(-) cells are a rare, quiescent, primi
tive progenitor subpopulation lacking expression of lymphoid and myelo
id lineage specific antigens. Although myeloid, erythroid, and megakar
yocytic differentiation from these cells has been described, B lineage
differentiation has not been demonstrated previously. We report here
that highly enriched human B cell progenitors can be consistently gene
rated from CD34(+)CD38(-) cord blood cells using long-term culture on
the murine stromal line, S17, in the absence of added cytokines., Afte
r 6-8 weeks, cell numbers increased up to 160-fold, and cultures conta
ined >80-90% CD10(+)CD19(+) B progenitors. Consistent with previous re
ports describing delayed myeloid cell differentiation from CD34(+)CD38
(-) cells, production of B cell progenitors from CD34(+)CD38(-) cord b
lood cells was delayed 2-1 weeks relative to cultures initiated with e
ither CD34(+)CD38(bright) or CD34(+)CD38(dim) progenitors. Addition of
Flt3 ligand to long-term cultures resulted in a 2-3-fold greater incr
ease in the number of CD19(+) cells generated after 4-8 weeks. The sel
ective outgrowth of B cell progenitors using this culture model will b
e useful for a range of in vitro studies using primitive hematopoietic
progenitors.